Special Drug Use Investigation for AMERGE® Tablet (Long-term)

Trial of Comprehensive Migraine Intervention

NCT01071317 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention

NCT03238781 ·Status: COMPLETED ·Phase: PHASE2

Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE)

NCT05550207 ·Status: COMPLETED ·Phase: PHASE3

Single-Ascending Dose Study of AMG 333 in Healthy Subjects and Subjects With Migraines

NCT01953341 ·Status: COMPLETED ·Phase: PHASE1

Migraine Prophylaxis With Clopidogrel Trial

NCT02938182 ·Status: UNKNOWN ·Phase: PHASE4

Telcagepant (MK-0974) Long-Term Safety Study in Adult Participants With Acute Migraine (MK-0974-012)

NCT00443209 ·Status: COMPLETED ·Phase: PHASE3

ARISE-A Chinese Real-world Study of Rimegepant for the Acute Treatment of Migraine

NCT06439628 ·Status: ACTIVE_NOT_RECRUITING

Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine

NCT03828539 ·Status: COMPLETED ·Phase: PHASE4

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine

NCT03901482 ·Status: COMPLETED ·Phase: PHASE3

A Safety and Efficacy Study to Evaluate AMG 334 in Migraine Prevention

NCT02630459 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of Rimegepant for Migraine Prevention in Japanese Subjects (Japan Only)

NCT05399485 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.

NCT02174861 ·Status: COMPLETED ·Phase: PHASE2

A Study of Gastric Delay in Migraine Patients (3207-003)

NCT00548353 ·Status: COMPLETED ·Phase: PHASE1

Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study

NCT04084314 ·Status: COMPLETED ·Phase: PHASE4

Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episodic Migraine

NCT05861427 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine

NCT01248468 ·Status: COMPLETED ·Phase: PHASE4

An Efficacy and Safety of Proprietary Formulations of Oral Ketamine + Aspirin in Treatment of Acute Headache

NCT04860713 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only)

NCT05399459 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine

NCT01390324 ·Status: WITHDRAWN ·Phase: PHASE3

Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan

NCT00356603 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine

NCT02828020 ·Status: COMPLETED ·Phase: PHASE3

Treatments of Migraine with Triptans in Individuals with Elevated Cardiovascular Risk and in Pregnant Women

NCT05854992 ·Status: COMPLETED

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months

NCT00792103 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

NCT05125302 ·Status: RECRUITING ·Phase: PHASE3

A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data

NCT01381523 ·Status: COMPLETED